GL1X · GenesisL1 explorer

MolNFT v1 · #148735 · protein

Human BRD2 C-terminal bromodomain with (S)-5-(1-acetyl-2-cyclopropyl- 4-(2-(HYDROXYMETHYL)BENZYL)-1,2,3,4-tetrahydroquinoxalin-6-yl) pyrimidine-2-carboxamide

6FFF · Bromodomain-containing protein 2: “Human BRD2 C-terminal bromodomain with (S)-5-(1-acetyl-2-cyclopropyl…”. X-ray diffraction, 1 ligand (D7H), 1 pocket (best druggability 0.48). MolNFT v1 #148735 on GenesisL1: 3D structure, binding…

PDB
6FFF
Type
protein
Length
113 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bromodomain-containing protein 2
UniProt
P25440
Ligands
D7H
Pockets
1 · best druggability 0.48

Structure

x-ray diffraction · 1 distinct chain · 66% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABromodomain-containing protein 2protein11366% helix, 0% strandP25440

Ligands and binding sites

  • D7H · (S)-5-(1-acetyl-2-cyclopropyl-4-(2-(hydroxymethyl) benzyl)-1,2,3,4-tetrahydroquinoxalin-6-yl)pyrimidine-2-carboxamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11160.480.7921D7H

Compared structures

  • 6FFF · Human BRD2 C-terminal bromodomain with (S)-5-(1-acetyl-2-cyclopropyl-4-(2-(hydroxymethyl)b… · the same entry in another collection · chain A against A, TM-score 1.00
  • P25440 · AlphaFold monomer V2.0 prediction for bromodomain-containing protein 2 (P25440) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.